Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1986 1
1994 2
1995 1
1996 1
1998 1
2002 3
2004 1
2013 1
2014 2
2017 2
2018 2
2021 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Colo-pancreaticoduodenectomy for locally advanced colon carcinoma-feasibility in patients presenting with acute abdomen.
Chen JB, Luo SC, Chen CC, Wu CC, Yen Y, Chang CH, Chen YA, P'eng FK. Chen JB, et al. World J Emerg Surg. 2021 Feb 27;16(1):7. doi: 10.1186/s13017-021-00351-6. World J Emerg Surg. 2021. PMID: 33639983 Free PMC article.
BACKGROUND: En bloc right hemicolectomy plus pancreaticoduodenectomy (PD) is administered for locally advanced colon carcinoma that invades the duodenum and/or pancreatic head. ...Here, we aimed to evaluate the feasibility and outcomes of emergency cPD for pa …
BACKGROUND: En bloc right hemicolectomy plus pancreaticoduodenectomy (PD) is administered for locally advanced colon carcin …
Adoptive transfer of natural killer cells in combination with chemotherapy improves outcomes of patients with locally advanced colon carcinoma.
Li L, Li W, Wang C, Yan X, Wang Y, Niu C, Zhang X, Li M, Tian H, Yao C, Jin H, Han F, Xu D, Han W, Li D, Cui J. Li L, et al. Cytotherapy. 2018 Jan;20(1):134-148. doi: 10.1016/j.jcyt.2017.09.009. Epub 2017 Oct 19. Cytotherapy. 2018. PMID: 29056549 Clinical Trial.
BACKGROUND: Despite the availability of multiple treatment strategies, patients with advanced colon carcinoma (CC) have poor prognoses. The aim of this study was to evaluate the efficacy and safety of natural killer (NK) cell therapy in combination with chemo …
BACKGROUND: Despite the availability of multiple treatment strategies, patients with advanced colon carcinoma (CC) have …
Dysfunctional TLR1 reduces the therapeutic efficacy of chemotherapy by attenuating HMGB1-mediated antitumor immunity in locally advanced colorectal cancer.
Huang KC, Ke TW, Chen JY, Hong WZ, Chiang SF, Lai CY, Chen TW, Yang PC, Chen LC, Liang JA, Chen WT, Chao KSC. Huang KC, et al. Sci Rep. 2023 Nov 9;13(1):19440. doi: 10.1038/s41598-023-46254-1. Sci Rep. 2023. PMID: 37945630 Free PMC article.
Patients with the TLR1-N248S polymorphism (rs4833095), which causes loss-of-function in HMGB1-mediated TLR1-TLR2 signaling, may influence the therapeutic efficacy of adjuvant chemotherapy, leading to a high risk of distant metastasis within 5 years [HR = 1.694, 95% CI = 1.063-2.6 …
Patients with the TLR1-N248S polymorphism (rs4833095), which causes loss-of-function in HMGB1-mediated TLR1-TLR2 signaling, may influence th …
Phase II trial of high-dose melphalan and autologous bone marrow transplantation for metastatic colon carcinoma.
Leff RS, Thompson JM, Johnson DB, Mosley KR, Daly MB, Knight WA 3rd, Ruxer RL Jr, Messerschmidt GL. Leff RS, et al. J Clin Oncol. 1986 Nov;4(11):1586-91. doi: 10.1200/JCO.1986.4.11.1586. J Clin Oncol. 1986. PMID: 3534154
Further investigation is needed to define the role of this therapy in the care of advanced colon carcinoma....
Further investigation is needed to define the role of this therapy in the care of advanced colon carcinoma....
Secreted MUC1 mucins lacking their cytoplasmic part and carrying sialyl-Lewis a and x epitopes from a tumor cell line and sera of colon carcinoma patients can inhibit HL-60 leukocyte adhesion to E-selectin-expressing endothelial cells.
Zhang K, Baeckström D, Brevinge H, Hansson GC. Zhang K, et al. J Cell Biochem. 1996 Mar 15;60(4):538-49. doi: 10.1002/(SICI)1097-4644(19960315)60:4%3C538::AID-JCB10%3E3.0.CO;2-D. J Cell Biochem. 1996. PMID: 8707893
The purified H-CanAg inhibited adhesion of the leukocyte cell line HL-60 to E-selectin transfected COS-1 cells or interleukin-1 beta (IL-1 beta)-activated human umbilical vein endothelial cells. Sera from two patients with advanced colon carcinoma containing …
The purified H-CanAg inhibited adhesion of the leukocyte cell line HL-60 to E-selectin transfected COS-1 cells or interleukin-1 beta (IL-1 b …
5-Fluorouracil plus interferon alpha-2a compared to 5-fluorouracil alone in the treatment of advanced colon carcinoma: a multicentric randomized study.
Palmeri S, Meli M, Danova M, Bernardo G, Leonardi V, Dastoli G, Rausa L, Russo A, Filippelli G, Palmieri G, Russo A, Della Vittoria Scarpati M, Lo Russo V, Di Lauro L, Colucci G, Bruni G, Piazzi M, Gebbia N, Spada S. Palmeri S, et al. J Cancer Res Clin Oncol. 1998;124(3-4):191-8. doi: 10.1007/s004320050154. J Cancer Res Clin Oncol. 1998. PMID: 9619746 Clinical Trial.
Cytoreductive Surgery and Intraperitoneal Hyperthermic Chemotherapy (HIPEC) by Minimally Invasive Approach, an Initial Experience.
Arjona-Sanchez A, Rufian-Peña S, Sanchez-Hidalgo JM, Casado-Adam A, Cosano-Alvarez A, Briceño-Delgado J. Arjona-Sanchez A, et al. World J Surg. 2018 Oct;42(10):3120-3124. doi: 10.1007/s00268-018-4634-6. World J Surg. 2018. PMID: 29691625
The different diagnoses were low-grade pseudomyxoma peritonei (2), benign multicystic mesothelioma (2), primary epithelial ovarian carcinomatosis (2) and locally advanced colon carcinoma T4 (2). The median age was 54 (20-62) years, the median PCI was 3 (2-4), …
The different diagnoses were low-grade pseudomyxoma peritonei (2), benign multicystic mesothelioma (2), primary epithelial ovarian carcinoma …
Expression of MUC1 recognized by monoclonal antibody MY.1E12 is a useful biomarker for tumor aggressiveness of advanced colon carcinoma.
Suzuki H, Shoda J, Kawamoto T, Shinozaki E, Miyahara N, Hotta S, Iizuka Y, Nakahara A, Tanaka N, Yanaka A, Irimura T. Suzuki H, et al. Clin Exp Metastasis. 2004;21(4):321-9. doi: 10.1023/b:clin.0000046133.35133.cc. Clin Exp Metastasis. 2004. PMID: 15554388
To address the need for new prognostic parameters in advanced colon carcinoma that could add insights into the aggressiveness of tumors, the expression levels of MUC1 recognized by a monoclonal antibody (mAb) MY.1E12 in archival specimens from 123 Japanese pa …
To address the need for new prognostic parameters in advanced colon carcinoma that could add insights into the aggressi …
Excellent prognosis of node negative patients after sentinel node procedure in colon carcinoma: a 5-year follow-up study.
Braat AE, Pol RA, Oosterhuis JW, de Vries JE, Mesker WE, Tollenaar RA. Braat AE, et al. Eur J Surg Oncol. 2014 Jun;40(6):747-55. doi: 10.1016/j.ejso.2013.10.003. Epub 2013 Oct 23. Eur J Surg Oncol. 2014. PMID: 24220573
PATIENTS AND METHODS: Between May 2002 and January 2004, the SN-procedure was performed in 55 patients that underwent elective resection for clinically non-advanced colon carcinoma. A control group of 110 patients was identified from a cohort between January …
PATIENTS AND METHODS: Between May 2002 and January 2004, the SN-procedure was performed in 55 patients that underwent elective resection for …
18 results